Recent studies have reported that pulmonary vascular endothelial cells from patients with PAH have decreased PHD2 expression and that mice with endothelial cell-targeted disruption of the gene for PHD2 (EGLN1) develop obliterated vascular remodeling and complex lesions, similar to patients with PAH (141). Here, EGLN1 is linked to pulmonary arterial hypertension.